Charles River Laboratories (NYSE:CRL)

CAPS Rating: 4 out of 5

The Company is a global provider of solutions that advance the drug discovery and development process. It provides the animal research models required in research and development for new drugs, devices and therapies.

Recs

0
Player Avatar cmgibson2 (< 20) Submitted: 5/8/2008 9:14:23 AM : Outperform Start Price: $64.37 CRL Score: -45.86

I haven't been watching these stocks long, but these look the most appetizing as of right now.

Featured Broker Partners


Advertisement